AT&T INC. FILES (8-K) Disclosing Other Events

Edgar Glimpses |

Item 8.01 Other Events.

AT&T Inc. (referred to as "AT&T," "we," or "our") stated in our Form 10-K filed on , that our commitment to purchase 600 MHz spectrum licenses for which we submitted bids is expected to be more than satisfied by the deposits made to the Federal Communications Commission (FCC) in the third quarter of 2016. Consistent with that commitment, we were the successful bidder for spectrum in 18 markets, and expect to pay a purchase price of approximately $900 million. With our previous deposit made in , a refund in the amount of $1.4 billion is expected from the FCC.


Information set forth in this filing contains financial estimates and other forward-looking statements that are subject to risks and uncertainties, and actual results may differ materially. A discussion of factors that may affect future results is contained in AT&T's filings with the Securities and Exchange Commission. AT&T disclaims any obligation to update or revise statements contained in this filing based on new information or otherwise. --------------------------------------------------------------------------------


Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                     AT&T INC.

Date: By: /s/ Debra L. Dial

                         Debra L. Dial
                     Senior Vice President and Controller

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Invictus MD Strategies Corp

Invictus MD Strategies Corp is focused on two main verticals within the Canadian cannabis sector under the Access to Cannabis for Medical Purposes Regulations having investment in Acreage Pharms Ltd.,…